Astonea Labs IPO Allotment to Be Out Soon: Steps to Check Status Online, GMP in Focus as Listing Nears

Mumbai, May 31, 2025 — The highly anticipated Astonea Labs IPO allotment is likely to be finalized soon, marking a key milestone for investors who applied in this NSE SME issue. After a robust subscription across investor categories, all eyes are now on the allotment outcome, grey market premium (GMP), and the eventual listing performance of this promising pharmaceutical and wellness company.

In this report, we detail everything you need to know — from checking the IPO allotment status online to understanding GMP trends and what the road ahead looks like for investors awaiting listing gains.

What Is Astonea Labs and Why Is This IPO in Focus?

Astonea Labs Ltd is a healthcare and pharmaceutical company engaged in the development, manufacturing, and distribution of wellness products, nutraceuticals, and therapeutic solutions. The company caters to a B2B clientele across India and exports to several international markets, particularly in Asia and Africa.

The IPO has attracted strong interest from both retail and institutional investors, thanks to:

• The company's high-margin product portfolio

• A debt-light balance sheet

• Strong growth in exports

• Robust operating cash flows

Astonea Labs IPO: Key Details at a Glance

Subscription Status: Strong Demand Across the Board

Astonea Labs IPO witnessed stellar subscription, driven by bullish sentiment in the SME segment and strong fundamentals. Here's how each investor category fared:

Such oversubscription implies that allotment will be made via lottery for retail investors, with only a small fraction likely to receive shares.

How to Check Astonea Labs IPO Allotment Status Online

Once the allotment is finalized (expected by June 3), you can check your allotment status via the registrar’s website or NSE.

 Option 1: Through Registrar's Website (Link Intime India)

1. Go to ‘Investor Services’ → ‘IPO Allotment Status’

2. Select Astonea Labs Ltd from the dropdown

3. Enter one of the following:

   • PAN Number

   • Application Number

   • DP/Client ID

4. Click on ‘Submit’ to view allotment status

 Option 2: Through NSE Website

1. Go to Market Data → Public Issues → Allotment Status

2. Select Astonea Labs IPO

3. Provide PAN or Application Number

4. Click on ‘Search’ to see if shares are allotted

Pro Tip: Have your PAN and application number handy to check status faster on Day 1.

Grey Market Premium (GMP) Update: Astonea Labs IPO GMP Today

As of May 31, 2025, the grey market premium (GMP) for Astonea Labs IPO stands at ₹30 per share, indicating a potential listing price of ₹125, based on the IPO issue price of ₹95.

GMP Trend Over the Last Few Days:

Market Sentiment: While GMP has slightly softened, it still suggests a listing gain of ~31.5%, reflecting healthy demand and strong subscription interest.

Listing Day Expectations: What Should Investors Watch?

If GMP trends hold and no major external market turbulence affects sentiment, Astonea Labs is likely to debut on a strong note.

Factors Supporting a Strong Listing:

• Oversubscription across categories

• Stable market conditions

• Strong fundamentals and export-led growth

• Debt-light balance sheet

Risks to Listing Performance:

• Broader market volatility

• Liquidity rotation into larger cap IPOs

• SME listing fatigue among retail investors

Analysts suggest that listing gains between 25–35% are realistic unless there's a broader market disruption.

Should You Hold or Book Profits Post-Listing?

If you are among the fortunate few who receive allotment, your strategy depends on your investment horizon:

 Book Profits If:

• You are a short-term investor

• GMP holds above ₹30–35 at listing

• You need capital liquidity

 Hold for Medium-Term If:

• You believe in the company's long-term growth

• You expect exports and new products to drive margins

• You can tolerate SME volatility

Some analysts believe the company could re-rate further if it expands its product portfolio and sees continued export traction.

Brokerages and Market Experts Weigh In

While no major brokerage has officially rated Astonea Labs due to its SME classification, market analysts tracking IPOs have shared a positive outlook.

Analyst Commentary:

"Astonea Labs offers a compelling combination of revenue growth, lean balance sheet, and an experienced promoter background. Investors should view it beyond just listing pop, especially given the company's focus on wellness and healthcare," said Ravi Singhal, CEO, GCL Broking.

Another SME IPO analyst added:

“The IPO has priced in value with reasonable valuation multiples. GMP remains strong, which shows healthy demand from the grey market despite the overall market being flat this week.”

Fundamentals Snapshot: Astonea Labs Financial Highlights

The steady improvement in revenue and profitability over the last two years underpins the strong interest in this IPO.

Timeline Recap

Final Word: Watch for Allotment, But Plan Listing Strategy

Astonea Labs IPO is yet another example of how the SME platform is attracting investor interest amid strong growth stories and fundamentals. With allotment around the corner, applicants must prepare to check their status and decide their listing-day approach based on personal goals and market cues.

If you’re allotted, consider partial profit booking or holding based on your risk appetite. If not allotted, keep the company on your watchlist for potential post-listing entry depending on price action.